Market research
UU4.F AS Olainfarm
F EUR Not available
Latest close
As of 04 Dec 2024
Test a moving-average rule with historical data.
Market facts
- Market cap
- 123M
- P/E ratio
- 8.31
- Analyst target
- Not available
- Dividend yield
- 2.0%
- Beta
- 0.39
Profile
Instrument facts
- Exchange
- F
- Currency
- EUR
- Sector
- Not available
- Industry
- Not available
- ISIN
- Not available
- Market cap
- 123M
- P/E ratio
- 8.31
- Analyst target
- Not available
- Dividend yield
- 2.0%
- Beta
- 0.39
About
About AS Olainfarm
AS Olainfarm manufactures and distributes chemical and pharmaceutical products in Latvia. The company operates through five segments: Manufacturing of Medicines, Wholesale, Retail Sale, Compression Products, and Other. It provides over the counter products, including medicines for anti-allergy, anti-inflammatory and analgesic, antibacterial, common cold, and digestive systems; and prescription medicines for antibacterial, digestive systems, metabolic, antifungal, and antiviral, as well as for cardiovascular health and nervous systems; and food supplements. The company also offers active pharmaceutical ingredients (APIs) and intermediates; pharmacovigilance services; and QC/QA, regulatory, APIs and intermediates development, final dosage forms development, and contract manufacturing services. In addition, it engages in the sale of medicine and other products to retailers; operation of a pharmacy chain under the Latvijas Aptieka name; production and sale of elastic and compression materials, food supplements, ecological pharmaceuticals and food additives, herbal teas and infusions, and ecological cosmetics; and provision of travelling, cosmetics distribution, marketing, investment property, and public services. The company also exports its products to approximately 60 countries. AS Olainfarm was founded in 1972 and is based in Olaine, Latvia. As of December 7, 2021, AS Olainfarm operates as a subsidiary of AS AB CITY.
Research context
AS Olainfarm appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the UU4.F discussion.
5 years, 6 months ago
AS Olainfarm is currently in a long term uptrend where the price is trading 24.4% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.8.
AS Olainfarm's total revenue sank by 30.4% to $23M since the same quarter in the previous year.
Its net income has dropped by 170.0% to $-5M since the same quarter in the previous year.
Finally, its free cash flow grew by 76.5% to $8M since the same quarter in the previous year.
Based on the above factors, AS Olainfarm gets an overall score of 3/5.